Factors that influence the volatile organic compound content in human breath

Journal of Breath Research

Volumn 11, Issue 1, 2017, Pages

  Blanchet, L ^a,b,c   Smolinska, A ^b,c   Baranska, A ^a,b   Tigchelaar, E ^d   Swertz, M ^d   Zhernakova, A ^a,d   Dallinga, J W ^b   Wijmenga, C ^d   Van Schooten, F J ^b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DARTMOUTH COLLEGE   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

breath analysis; confounding factors; metabolism; volatile organic compounds

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; VOLATILE ORGANIC COMPOUND; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; BLOOD CELL COUNT; BODY MASS; BREATH ANALYSIS; BREATHING; CHOLESTEROL BLOOD LEVEL; CHROMATOGRAPHY; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG THERAPY; EXPIRED AIR; FEMALE; GENDER; HUMAN; MAASTRICHTIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NETHERLANDS; POPULATION RESEARCH; SMOKING; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CONTRACEPTION; EPIDEMIOLOGY; EXHALATION; LEUKOCYTE COUNT; MASS FRAGMENTOGRAPHY; PROCEDURES;

AGE FACTORS; BIOMARKERS; BODY MASS INDEX; BREATH TESTS; CASE-CONTROL STUDIES; CHOLESTEROL; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRACEPTION; EXHALATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NETHERLANDS; SMOKING; VOLATILE ORGANIC COMPOUNDS;

EID: 85015622410     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7163/aa5cc5     Document Type: Article

References (66)

1. Amann A et al 2014 The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva J. Breath Res. 8 034001
2. Costello B D et al 2014 A review of the volatiles from the healthy human body J. Breath Res. 8 014001
3. Cao W Q and Duan Y X 2006 Breath analysis: potential for clinical diagnosis and exposure assessment Clin. Chem. 52 800-11
4. Boots A W, van Berkel J J, Dallinga J W, Smolinska A, Wouters E F and van Schooten F J 2012 The versatile use of exhaled volatile organic compounds in human health and disease J. Breath Res. 6 27108
5. Kwak J and Preti G 2011 Volatile disease biomarkers in breath: a critique Curr. Pharm. Biotechnol. 12 1067-74
6. Klaassen E M M et al 2014 Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age Am. J. Respiratory Crit. Care Med. 191 201-7
7. Fens N et al 2009 Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma Am. J. Respiratory Crit. Care Med. 180 1076-82
8. Smolinska A et al 2014 Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children PLoS One 9 e95668
9. Van Vliet D et al 2016 Association between exhaled inflammatory markers and asthma control in children J. Breath Res. 10 016014
10. Robroeks C M H H T et al 2010 Metabolomics of volatile organic compounds in cystic fibrosis patients and controls Pediatric Res. 68 75-80
11. van Mastrigt E et al 2016 Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis J. Breath Res. 10 026003
12. Van Berkel J J B N et al 2010 A profile of volatile organic compounds in breath discriminates COPD patients from controls Respiratory Med. 104 557-63
13. Christiansen A, Davidsen J R, Titlestad I, Vestbo J and Baumbach J 2016 A systematic review of breath analysis and detection of volatile organic compounds in COPD J. Breath Res. 10 034002
14. Gaida A et al 2016 A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD J. Breath Res. 10 026006
15. Santini G et al 2016 Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers J. Breath Res. 10 017102
16. Kolk A H J et al 2012 Breath analysis as a potential diagnostic tool for tuberculosis Int. J. Tuberc. Lung D 16 777-82
17. Scott-Thomas A, Epton M and Chambers S 2013 Validating a breath collection and analysis system for the new tuberculosis breath test J. Breath Res. 7 037108
18. Zetola N M et al 2016 Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples J. Infect. in press
19. Sahota A S et al 2016 A simple breath test for tuberculosis using ion mobility: a pilot study Tuberculosis 99 143-6
20. Zhu J, Bean H D, Wargo M J, Leclair L W and Hill J E 2013 Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints J. Breath Res. 7 016003
21. Phillips M et al 2007 Volatile biomarkers of pulmonary tuberculosis in the breath Tuberculosis 87 44-52
22. Bos L D, Meinardi S, Blake D and Whiteson K 2016 Bacteria in the airways of patients with cystic fibrosis are genetically capable of producing VOCs in breath J. Breath Res. 10 047103
23. Shestivska V et al 2015 Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis J. Breath Res. 9 027104
24. Bean H D, Dimandja J-M D and Hill J E 2012 Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry J. Chromatogr. 901 41
25. Boots A W et al 2014 Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry J. Breath Res. 8 027106
26. Rees C A, Smolinska A and Hill J E 2016 The volatile metabolome of Klebsiella pneumoniae in human blood J. Breath Res. 10 027101
27. de Heer K et al 2016 eNose technology can detect and classify human pathogenic molds in vitro: a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae J. Breath Res. 10 036008
28. Gordon S M, Szidon J P, Krotoszynski B K, Gibbons R D and O'Neill H J 1985 Volatile organic compounds in exhaled air from patients with lung cancer Clin. Chem. 31 1278-82 (http://clinchem.aaccjnls.org/content/31/8/1278.long)
29. Schallschmidt K et al 2016 Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study J. Breath Res. 10 046007
30. Gasparri R et al 2016 Volatile signature for the early diagnosis of lung cancer J. Breath Res. 10 016007
31. Phillips M, Cataneo R N, Greenberg J, Grodman R and Salazar M 2003 Breath markers of oxidative stress in patients with unstable angina Heart Dis. 5 95-9
32. Cikach F S Jr and Dweik R A 2012 Cardiovascular biomarkers in exhaled breath Prog. Cardiovascular Dis. 55 34-43
33. Phillips M, Cataneo R N, Saunders C, Hope P, Schmitt P and Wai J 2010 Volatile biomarkers in the breath of women with breast cancer J. Breath Res. 4 026003
34. Ilan Y 2007 Review article: the assessment of liver function using breath tests Alimentary Pharmacol. Ther. 26 1293-302
35. Portincasa P, Grattagliano I, Lauterburg Bernhard H, Palmieri Vincenzo O, Palasciano G and Stellaard F 2006 Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis Clin. Sci. 111 135-43
36. Park G J H et al 2011 Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13C-caffeine breath test J. Gastroenterol. Hepatol. 26 1411-6
37. Verdam F J et al 2013 Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath J. Hepatol. 58 543-8
38. Kokoszka J, Nelson R L, Swedler W I, Skosey J and Abcarian H 1993 Determination of inflammatory bowel disease activity by breath pentane analysis Dis. Colon Rectum 36 597-601
39. Ahmed I, Greenwood R, Costello B, Ratcliffe N and Probert C S 2016 Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease Alimentary Pharmacol. Ther. 43 596-611
40. Ahmed I, Greenwood R, Costello B D, Ratcliffe N M and Probert C S 2013 An investigation of fecal volatile organic metabolites in irritable bowel syndrome PLoS One 8 e58204
41. Hicks L C et al 2015 Analysis of exhaled breath volatile organic compounds in inflammatory bowel disease: a pilot study J. Crohns Colitis 9 731-7
42. Patel N et al 2014 Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study Alimentary Pharmacol. Ther. 40 498-507
43. Pelli M A, Trovarelli G, Capodicasa E, De Medio G E and Bassotti G 1999 Breath alkanes determination in ulcerative colitis and crohn's disease Dis. Colon Rectum 42 71-6
44. Bodelier A G L et al 2015 Volatile organic compounds in exhaled air as novel marker for disease activity in crohn's disease: a metabolomic approach Inflammatory Bowel Dis. 21 1776-85
45. Fent K W et al 2015 Volatile organic compounds off-gassing from firefighters' personal protective equipment ensembles after use J. Occup. Environ. Hyg. 12 404-14
46. National Research Council (USA) Committee on Contaminated Drinking Water at Camp Lejeune 2009 Systemic exposures to volatile organic compounds and factors influencing susceptibility to their effects Contaminated Water Supplies at Camp Lejeune: Assessing Potential Health Effects (Washington, DC: National Academies Press)
47. Lourencetti C et al 2010 New method for determination of trihalomethanes in exhaled breath: applications to swimming pool and bath environments Anal. Chim. Acta 662 23-30
48. Vereb H, Dietrich A M, Alfeeli B and Agah M 2011 The possibilities will take your breath away: breath analysis for assessing environmental exposure Environ. Sci. Technol. 45 8167-75
49. Bödeker B, Davies A, Maddula S and Baumbach J 2010 Biomarker validation - room air variation during human breath investigations Int. J. Ion. Mobil. Spectrom. 13 177-84
50. Joachim D P, Matthew A S and Terence H R 2013 Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders J. Breath Res. 7 017107
51. Das M K et al 2014 Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS Anal. Chem. 86 1229-37
52. Stolk R P et al 2008 Universal risk factors for multifactorial diseases - lifelines: a three-generation population-based study Eur. J. Epidemiol. 23 67-74
53. Tigchelaar E F et al 2015 Cohort profile: lifelines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics BMJ Open 5 e006772
54. Watson J T and Sparkman O D 2007 Introduction to Mass Spectrometry: Instrumentation, Applications and Strategies for Data Interpretation 4th edn (Chichester; Hoboken, NJ: Wiley) 818 pp xxiv
55. Smolinska A, Hauschild A C, Fijten R R, Dallinga J W, Baumbach J and van Schooten F J 2014 Current breathomics - a review on data pre-processing techniques and machine learning in metabolomics breath analysis J. Breath Res. 8 027105
56. Engel J et al 2013 Breaking with trends in pre-processing? TRAC Trends Anal. Chem. 50 96-106
57. Aberg K M, Torgrip R J, Kolmert J, Schuppe-Koistinen I and Lindberg J 2008 Feature detection and alignment of hyphenated chromatographic-mass spectrometric data. Extraction of pure ion chromatograms using Kalman tracking J. Chromatogr. A 1192 139-46
58. Engel J et al Regularized MANOVA (rMANOVA) in untargeted metabolomics Anal. Chim. Acta 899 1-12
59. Besag J and Clifford P 1991 Sequential Monte-Carlo P-values Biometrika 78 301-4
60. Breiman L 2001 Random forests Mach. Learn. 45 5-32
61. Berchtold C, Meier L and Zenobi R 2011 Evaluation of extractive electrospray ionization and atmospheric pressure chemical ionization for the detection of narcotics in breath Int. J. Mass Spectrom. 299 145-50
62. Blake N J et al 2004 Carbonyl sulfide and carbon disulfide: large-scale distributions over the western Pacific and emissions from Asia during TRACE-P J. Geophys. Res.-Atmos. 109 D15S05
63. Khalil M A K and Rasmussen R A 1984 Global sources, lifetimes and mass balances of carbonyl sulfide (OCS) and carbon disulfide (CS2) in the earth's atmosphere Atmos. Environ. 18 1805-13
64. Verma Y and Rana S V S 2003 Gender differences in the metabolism of benzene, toluene and trichloroethylene in rat with special reference to certain biochemical parameters J. Environ. Biol. 24 135-40
65. Vitali B et al 2010 Impact of a synbiotic food on the gut microbial ecology and metabolic profiles BMC Microbiol. 10 4
66. Beauchamp J 2011 Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath J. Breath Res. 5 037103